• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX (TRIVASCULAR INC.) OVATION IX; ILIAC LIMB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX (TRIVASCULAR INC.) OVATION IX; ILIAC LIMB Back to Search Results
Model Number TV-IL1416120-J
Medical Device Problem Code Occlusion Within Device (1423)
Health Effect - Clinical Codes Ischemia (1942); Occlusion (1984); Pain (1994); Thrombosis (2100); Claudication (2550); Blood Loss (2597)
Date of Event 01/09/2018
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Endologix will continue to investigate the reported event.The patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.A final report will be submitted once the investigation of the reported event has concluded.
 
Event or Problem Description
An ovation ix iliac limb stent graft was implanted to treat an abdominal aortic aneurysm.Patient returned for unknown reason where physician observed thrombosis of the right limb.The right limb was reported to have collapsed in the leg of the main body.The physician elected to re-intervene by explanting the device, successfully resolving the thrombosis.The patient is reported to be doing well post-procedure.As of the date of this report, there have been no additional patient sequelae reported.
 
Additional Manufacturer Narrative
Based on the clinical assessment for this event, the most likely cause of the occlusion within the aortic body and bilateral iliac limbs was found to be anatomy related due to the patient's hypercoagulable systemic condition.The reported right iliac limb stent buckling also likely contributed to the event.Procedure related harms include 2000 ml blood loss and additional surgical procedures.The patient was discharged on the seventh post operative day to their prior treatment facility and no additional patient sequelae has been reported.A review of the device quality records shows that the device demonstrated compliance to established procedures and specifications at the time of manufacture.Codes: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
ILIAC LIMB
Manufacturer (Section D)
ENDOLOGIX (TRIVASCULAR INC.)
3910 brickway blvd.
santa rosa CA 95403
MDR Report Key7250080
Report Number3008011247-2018-00017
Device Sequence Number16381083
Product Code MIH
UDI-Device IdentifierM701TVIL1416120J1
UDI-Public+M701TVIL1416120J1/$$3200105FS07211636G
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2017
Device Explanted Year2018
Reporter Type Manufacturer
Report Source company representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 01/09/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date01/31/2020
Device Model NumberTV-IL1416120-J
Device Catalogue NumberTV-IL1416120-J
Device Lot NumberFS072116-36
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Received by Manufacturer 01/09/2018
Supplement Date Received by Manufacturer01/09/2018
Initial Report FDA Received Date02/07/2018
Supplement Report FDA Received Date04/27/2018
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age68 YR
-
-